COVID-19

Overview

At the end of December 2019, Chinese public health authorities reported several cases of acute respiratory syndrome in Wuhan City, Hubei province, China. Chinese scientists soon identified a novel coronavirus as the main causative agent. The disease is now referred to as coronavirus disease 2019 (COVID-19), and the causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a new strain of coronavirus that has not been previously identified in humans.

The initial outbreak in Wuhan spread rapidly, affecting other parts of China. Cases were soon detected in several other countries. Outbreaks and clusters of the disease have since been observed in Asia, Europe, Australia, Africa and the Americas.

For a quick overview, please refer to the following pages:

 

The COVID-19 pandemic is rapidly evolving, and outbreak investigations are ongoing. ECDC is closely monitoring this outbreak, providing risk assessments, public health guidance, and advice on response activities to EU Member States and the EU Commission.

Latest updates

Publication

Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update

Risk assessment -

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Publication

Communicable disease threats report, 29 March-4 April 2020, week 14

Publication -

Publication

An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA

Technical report -

Data

Algorithm for the management of contacts of probable or confirmed COVID-19 cases

Tool, Patient and case management -

Situation update 5 April 2020, dataset collected 6:00-10:00 CET

1 174 652 cases
Worldwide
64 400 deaths
Whereof 44 955 deaths in the EU/EEA and the UK.
555 809 cases
in the EU/EEA and the UK.